基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Discover the full record of transactions filed by Conte Lisa A, 董事长兼首席执行官. Director active across 1 company, notably Jaguar Health, Inc.. In total, 10 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €17k. History available since 13 September 2021. The latest transaction was filed on 11 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
CONTE LISA A is Président-Directeur Général at Jaguar Health, Inc. The record includes 10 filings in total, and, across the sampled recent filings, purchases total EUR 16932, sales total EUR 0, with a first filing on 2022-03-30 and a last filing on 2026-01-21. The most common transaction nature is Levée d'options.